Well I will correct my prior view. I have seen all my small cap start up biotechs stagnate and go down, since the Supreme courts ruling, growth in these guys is not on the radar for the short term. Now with the quarter report with allthe warnings attached, does not make me sit to comfortabley, like they are positioning us all for not good news, or maybe a buyout on the radar??? give it till the end of november before i decide to sell my positions.
More dilution announced after the close today. Needed to raise money so they printed more pieces of paper as stock and warrants. This is about the only way this firm makes any money-by printing stock certificates IMO. Come on guys! How about actually doing some research and having a real product with real sales!